StoryCenter’s “Digital Storytelling Workshop” brings a small group of people together to share true personal stories from their lives, as short digital videos.
Archive for category: Advocacy
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
Nominate Hep C Elimination Champion/Team for NYS DOH Commissioner World AIDS Day Award!
Advocacy, NewsThe New York State Department of Health Commissioners’ recognition awards recognize accomplishments in the areas of: HIV, STD, HCV, LGBT, drug user health or youth sexual health. For hepatitis C, the New York State Department of Health is recognizing individuals or teams commit...
Dear allies, friends, and colleagues, Recently, the Trump administration has announced that it will be drafting its own national HIV “Ending the Epidemic” plan by mid-2019. This obviously raises many concerns. First and foremost, can the drafting of such a plan truly be led b...
NY Governor Announces First-In-Nation Task Force To Eliminate Hepatitis C
Advocacy, News, HepCX NewsGovernor Andrew M. Cuomo today announced the nation's first strategy to eliminate hepatitis C, including the establishment of a Hepatitis C Elimination Task Force that will advise the state as it implements its plan going forward.
NYS Medicaid Removes Hep C Experienced Provider Requirement from Prior Authorization Criteria
Advocacy, News, HepCX NewsNYS Medicaid Removes Hep C Experienced Provider Requirement from Prior Authorization Criteria
Hep B Testing Health Code Amendment Adopted in NYC! In order to improve complete hepatitis B diagnostic testing, care and treatment rates in NYC at the population level, the NYC Board of Health adopted an amendment to the Health Code. The NYC Health Department will receive ne...
At the meeting, Hep Free NYC Ad Board members developed Hep Free NYC goals for 2018.
Sign on to a letter urging Congressional leaders to allocate opioid funding to CDC’s viral hepatitis program in FY2018.
The primary goals of the Manual are to increase advocates' knowledge about available HCV tests and treatments and to jumpstart discussions on advocacy strategies that can be used to open up affordable access for more people with HCV.









